Chemotherapy Flashcards

1
Q

Drug causes Pulmonary Fibrosis

A

Bleomycin
Busulfan
Bromocriptine
Amiodarone
Nitrofurantoin
MTX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rescue therapy for MTX

A

Leucuvorin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Rescue therapy for Cyclophosphamide

A

MESNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rescue therapy for Doxorubicin

A

Dexrazoxane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rescue therapy for Cisplatin

A

Amifostine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Most specific for the S phase of the cell cycle

A

Cytarabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Use for Acute Leukemia (AML, ALL), CML in BLAST CRISIS

A

Cytarabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antimetabolites mimics ___________-

A

purine and pyrimidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prevent microtubule assembly –> arrest at M phase

A

Vincrisitine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

alkylating agent that is designed for brain tumors – highly lipophilic and can cross BBB

A

Nitrosureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Inhibits topoisomerase I

A

Topotecan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Inhibits DNA topoisomerase II (DNA gyrase)

A

Etoposide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Interferes with mitotic spindle

A

Paclitaxel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

inhibits de novo purine nucleotide synthesis

A

6-mercaptopurine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

causes THYMINELESS death of cells

A

5-fluorouracil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Most specific for G2 PHASE

A

Bleomycin

17
Q

Reduces estrogen synthesis by inhibiting aromatase

A

Anastrozole

18
Q

Inhibits tyrosine kinase activity of the protein product of BCR ABL oncogene in CML

A

Imatinib

19
Q

inhibits binding of VEGF to VEGFR; inhibits tumor vascular permeability

A

Bevacizumab

20
Q

CD20 inhibitor

A

Rituximab

21
Q

Binds to EGFR and inhibits downstream EGFR signaling

A

cetuximab

22
Q

uses for Acute promyleocytic leukemia

A

all trans retinoic acid